Supernus Pharmaceuticals
SUPN
SUPN
64 hedge funds and large institutions have $234M invested in Supernus Pharmaceuticals in 2013 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 25 increasing their positions, 14 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
9% more call options, than puts
Call options by funds: $2.48M | Put options by funds: $2.27M
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
Holders
64
Holding in Top 10
3
Calls
$2.48M
Puts
$2.27M
Top Buyers
| 1 | +$10.6M | |
| 2 | +$10.4M | |
| 3 | +$8.92M | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$2.97M |
| 5 |
MOACM
Mutual of America Capital Management
New York
|
+$2.93M |
Top Sellers
| 1 | -$1.07M | |
| 2 | -$733K | |
| 3 | -$683K | |
| 4 |
O
OrbiMed
New York
|
-$448K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$385K |